Tian Dan-Li, Liang Chun-Po, Liang Jing, Chen Hong
Tianjin First Center Hospital Tianjin 300192,China.
General Hospital of Tianjin Medical University Tianjin 300052,China.
Zhongguo Zhong Yao Za Zhi. 2019 Jun;44(12):2532-2537. doi: 10.19540/j.cnki.cjcmm.20190321.207.
According to drug design flattening principle,a series of novel indole podophyllotoxin derivatives which were introduced different indole substituents in C-4 position on the basis of podophyllotoxin nucleus were synthesized with the starting material podophyllotoxin and 1 H-indole-5-carboxylic acid. Its anti-tumor activity in vitro was tested in order to screen for high-efficiency and low-toxic compounds. Six target compounds were synthesized,and were confirmed by1 H-NMR,(13)C-NMR,HR-ESI-MS and melting point determination analysis. All these target compounds were not reported by previous literature. Using etoposide as positive control drug,all the target compounds were screened for cytotoxicity against He La cells,K562 cells and K562/A02 cell in vitro by MTT method. The antitumor activity screening results showed that compounds 4 b,4 e,4 f exhibited higher inhibitory rate against He La cells and K562 cells than those of control drug VP-16. This route has the advantages on simple operation and reasonable design,provides some practical reference value for the further development on the structure modification of podophyllotoxin and study on anti-tumor activity.
根据药物设计的扁平化原理,以鬼臼毒素为原料,与1H-吲哚-5-羧酸反应,合成了一系列在鬼臼毒素母核的C-4位引入不同吲哚取代基的新型吲哚类鬼臼毒素衍生物。测试了其体外抗肿瘤活性,以筛选高效低毒的化合物。合成了6个目标化合物,并通过1H-NMR、13C-NMR、HR-ESI-MS和熔点测定分析进行了确证。所有这些目标化合物均未见以往文献报道。以依托泊苷为阳性对照药,采用MTT法体外筛选所有目标化合物对HeLa细胞、K562细胞和K562/A02细胞的细胞毒性。抗肿瘤活性筛选结果表明,化合物4b、4e、4f对HeLa细胞和K562细胞的抑制率高于对照药VP-16。该路线操作简单、设计合理,为鬼臼毒素的结构修饰及抗肿瘤活性研究的进一步开展提供了一定的实用参考价值。